薬物療法を行った顎関節症患者の臨床的検討  [in Japanese] Clinical study of TMD patients treated with drug therapy in our clinic  [in Japanese]

Access this Article

Search this Article

Author(s)

    • 藤澤 健司 FUJISAWA Kenji
    • 徳島大学歯学部口腔外科学第一講座 First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
    • 横山 和博 YOKOYAMA Kazuhiro
    • 徳島大学歯学部口腔外科学第一講座 First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
    • 宮本 洋二 MIYAMOTO Youji
    • 徳島大学歯学部口腔外科学第一講座 First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
    • 鎌田 伸之 KAMATA Nobuyuki
    • 徳島大学歯学部口腔外科学第一講座 First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima
    • 長山 勝 MAGAYAMA Masaru
    • 徳島大学歯学部口腔外科学第一講座 First Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Tokushima

Abstract

顎関節症に対する薬物療法の有効性を把握する目的に, 1997年4月から2002年3月までの5年間に, 薬物療法を行った顎関節症患者180名を対象として臨床的検討を行った。<BR>性別では男性65例, 女性115例で, 年齢別では20歳台が54例と最も多かった。症型分類では, I型30例, II型39例, IIIa型33例, IIIb型58例, IV型19例であった。主訴は関節痛が134例と最も多く, 次いで開口障害42例の順であった。薬物療法単独が62例, 他の治療法と併用が118例であった。使用薬剤は非ステロイド系消炎鎮痛剤 (NSAIDs) ではアンピロキシカムが多く, 筋弛緩剤では全例に塩酸トルペリゾンを使用した。薬剤の投与方法はNSAIDs単独が114例, 筋弛緩剤単独が26例, 両者の併用が36例であった。<BR>薬物療法の効果が判定可能な134例について治療成績を評価したところ, 症状がすべて消失したのが15例 (11.2%), ほとんど消失したのが42例 (31.3%), 症状の改善がみられたのが35例 (26.1%) であり, 奏効率68.7%であった。症型別ではI型, II型の奏効率が, IIIa型, IIIb型, IV型よりも高かった。

To evaluate the efficacy of drug therapy in the treatment of patients with temporomandibular disorders, we investigated clinical characteristics and treatment outcome in 180 patients with TMD treated with drug therapy in our hospital from April 1997 to March 2002. The following results were obtained.<BR>The patients were 65 males and 115 females. The largest group of patients was the 20s age group (54 cases). Thirty patients were type I, 39 patients type II, 33 patients type IIIa, 58 patients type IIIb and 19 patients type IV. One hundred and thirty-four patients came to the hospital with the chief complaint of temporomandibular joint pain and 42 patients came with the chief complaint of trismus.<BR>We treated 62 cases with only drug therapy, and 118 cases with drug therapy and other therapies. We gave only non steroidal anti-inflammatory drugs (NSAIDs) in 114 cases, only muscle relaxants in 26 cases and both of them in 36 cases. The most frequently used drugs were ampiroxicam in NSAIDs, and tolperisone hydrochloride in muscle relaxants.<BR>As for prognosis in 134 cases, 15 cases (11.2%) were completely healed, 42 cases (31.3%) were almost completely healed, 35 cases (26.1%) had some improvements in their symptom, but 42 cases (31.3%) were not improved. Better clinical outcome was obtained in patients with type I and with type II.

Journal

  • Journal of the Japanese Society for the Temporomandibular Joint

    Journal of the Japanese Society for the Temporomandibular Joint 15(3), 260-265, 2003-12-20

    The Japanese Society for Temporomandibular Joint

References:  9

Cited by:  6

Codes

Page Top